Chances of a rate hike in July by the Federal Reserve rose as oil prices jumped on the latest developments in the Strait of Hormuz.

The Fed governor said inflation has expanded beyond the often-cited drivers such as the energy price spike in tariffs.

These are the stocks posting the largest moves midday.

The Senate Banking Committee approved the bill 15-9 in May, with two Democrats joining Republicans to advance the legislation.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

SpaceX went public a month ago in a record IPO. Elon Musk's space and AI company was added to the Nasdaq-100 last week.

Here are five key things investors need to know to start the trading day.

AI may either prompt some older workers to leave their jobs or help make their roles more efficient, research finds. Here's which careers may be most affected.

A structural shortage in labor supply across the semiconductor industry means the firms could be uniquely placed to grow EDA revenues.

Big banks are set to report booming Q2 revenue as the SpaceX IPO, Iran war volatility and a rebound in commercial lending fuel Wall Street's "sweet spot."

These are the stocks posting the largest moves premarket.

The platform is designed to alleviate problems the company's most active traders have run into, according to a memo provided to CNBC.

China has a saturated domestic market, which has led Chinese companies to look elsewhere to sell electric vehicles.

Meta said the planned Hyperion data center supercluster in Richland Parish, Louisiana, will be a 5GW facility and cost over $50 billion.

Helsing said "investor demand significantly exceeded the available allocation" for its $1.8 billion funding round.

Ahead of its second-quarter earnings, TSMC reported its June and first-half revenue for 2026.

Sam Altman insisted that Elon Musk was again obsessed with him because of an OpenAI model release earlier this week.

A majority of U.S. employees now want an AI sovereign wealth fund to hold corporations more accountable, according to a recent survey, as tech layoffs rise.

The investment bank released its Chinese AI model competitive positioning framework on Friday.

AI-related chip stocks have been volatile amid a debate over AI demand and spending.

Chip stocks had a wild but strong week. Meta led our portfolio higher.

ETF Action's Mike Akins is encouraging investors to boost exposure to groups that underperformed compared with major artificial intelligence stocks.

Interest in brain-computer interfaces is rising as it promises to help people with compromised neural abilities.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.

In the eight-plus months since Amazon announced its most expansive job cuts ever, laid off workers have been thrust into an increasingly saturated labor market.

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.

Companies are starting to choose AI models by task, cost and control, not just leaderboard rank.

The two companies entered into a high-profile partnership in 2024 when ChatGPT was integrated into the iPhone's operating system.

Apple stayed true to itself in the AI race, and Wall Street is finally rewarding the stock for it.

The Commerce Department will favorably review exports involving MGX, which used a stablecoin linked to President Trump's family for a $2B Binance investment.

Investors are also celebrating Meta's launch Thursday of Muse Spark 1.1.

These are some of the stocks posting the largest moves midday.

The S&P 500 trades around 28x trailing earnings versus 21x forward earnings. Experts say the spread mostly reflects high earnings expectations.

These are the stocks posting the largest moves premarket.

Its latest fundraising round provides the French biotech with enough cash to finance operations through 2029.

The update followed a high-stakes boardroom showdown with the group's supervisory board.

Federal Reserve Chairman Kevin Warsh on Thursday released names of the experts who will comprise five task forces to examine the institution's operations.

CNBC reached out to 50 companies about what are their trading policies for employees on prediction markets. A handful had an answer.

Odds that gas prices are above $3.50 on Election Day in November have jumped to 75% on the platform.

These are the stocks posting the largest moves midday.

Competition in the multitrillion-dollar market for retirement assets is fierce among managers like Goldman Sachs, BlackRock, Russell Investments and Mercer.

These are the stocks posting the largest moves in the premarket.

A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.

The investor believes regulators will eventually crack down on prediction markets after competition from the upstarts pressured the stocks of sportsbooks.

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

CNBC's Jim Cramer said investors should use the latest market rotation as an opportunity to buy high-quality companies.

Foreign aid cuts have "demonstrably worsened" the Ebola crisis, a virologist told CNBC.

CNBC's Jim Cramer said Moderna's expanding pipeline in treatments for cancer and other diseases provides a compelling long-term investment thesis.

Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an important role for patients.

The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.

Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.

Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for manufacturers to catch up.

Chan Zuckerberg Initiative's Biohub will offer new grants to the rare disease community while expanding its AI drug repurposing partnership with Every Cure.

IQVIA controls one of the world's largest databases of healthcare information that's closely integrated the clinical research process.

Several European countries issued red weather alerts as a fresh bout of extreme heat pushed temperatures beyond 40 degrees Celsius (104 degrees Fahrenheit).

UPS is announcing a new investment in healthcare logistics as demand for the temperature-controlled category booms, CNBC has learned exclusively.